Ugan, Y. Et Al. 2016. IS PROLIDASE AN ACTIVATION MARKER IN PATIENTS WITH RHEUMATOID ARTHRITIS?. ACTA MEDICA MEDITERRANEA , vol.32, no.2 , 313-316.

Ugan, Y., Sezen, H., DOĞRU, A., & Kucuk, A., (2016). IS PROLIDASE AN ACTIVATION MARKER IN PATIENTS WITH RHEUMATOID ARTHRITIS?. ACTA MEDICA MEDITERRANEA , vol.32, no.2, 313-316.

Ugan, Yunus Et Al. "IS PROLIDASE AN ACTIVATION MARKER IN PATIENTS WITH RHEUMATOID ARTHRITIS?," ACTA MEDICA MEDITERRANEA , vol.32, no.2, 313-316, 2016

Ugan, Yunus Et Al. "IS PROLIDASE AN ACTIVATION MARKER IN PATIENTS WITH RHEUMATOID ARTHRITIS?." ACTA MEDICA MEDITERRANEA , vol.32, no.2, pp.313-316, 2016

Ugan, Y. Et Al. (2016) . "IS PROLIDASE AN ACTIVATION MARKER IN PATIENTS WITH RHEUMATOID ARTHRITIS?." ACTA MEDICA MEDITERRANEA , vol.32, no.2, pp.313-316.

@article{article, author={Yunus Ugan Et Al. }, title={IS PROLIDASE AN ACTIVATION MARKER IN PATIENTS WITH RHEUMATOID ARTHRITIS?}, journal={ACTA MEDICA MEDITERRANEA}, year=2016, pages={313-316} }